<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01455610</url>
  </required_header>
  <id_info>
    <org_study_id>ZMS-001</org_study_id>
    <nct_id>NCT01455610</nct_id>
  </id_info>
  <brief_title>Resectability of Pancreatic Head Cancer by Contrast-enhanced MDCT:a Multi-center Study</brief_title>
  <official_title>Preoperative Evaluation of Resectability of Pancreatic Head Cancer by Contrast-enhanced MDCT:a Multi-center Study</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Meng Su Zeng</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Changhai Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Shanghai Cancer Hospital, China</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Ruijin Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Huashan Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Huadong Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Shanghai Zhongshan Hospital</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this multicenter and double-blind clinical trial is to prospectively assess
      the sensitivity, specificity, negative predictive value, positive predictive value, and
      accuracy in respectability of pancreatic head cancer with contrasted-enhanced MDCT and its
      various post processing techniques, taking operational and pathological records as the gold
      standard.
    </textblock>
  </brief_summary>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Not yet recruiting</last_known_status>
  <start_date>October 2011</start_date>
  <completion_date type="Anticipated">October 2012</completion_date>
  <primary_completion_date type="Anticipated">October 2012</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case-Only</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <enrollment type="Anticipated">140</enrollment>
  <condition>Adenocarcinoma of Head of Pancreas</condition>
  <eligibility>
    <study_pop>
      <textblock>
        Out-patients or in-patients,with(or suspected) pancreatic head cancer, both have MDCT
        examinaton and receive surgery treatment
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Patients with (or suspected) pancreatic head cancer

          -  Being examined by contrasted-enhanced MDCT

          -  Receiving surgical treatment (including palliative surgery) in all research centers

        Exclusion Criteria:

          -  Patients having (or suspected) pregnancy or breast-feeding

          -  Patients having allergic reactions to iodinated contrast agents or Hypersensitivity
             reactions to allergens(including drugs)

          -  Patients receiving ERCP before contrasted-enhanced MDCT examination

          -  Patients without surgery because of a high degree of surgical risk
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Mengsu Zeng, MD, PhD</last_name>
    <role>Study Chair</role>
    <affiliation>Radiology Department, Zhongshan Hospital of Fudan University</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Jianping Lu, MD,PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Radiology Department, Changhai Hospital Affiliated to Second Military Medical University</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Weijun Peng, MD, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Radiology Department, Cancer Hospital Affiliated to Fudan University</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Fuhua Yan, MD, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Radiology Department, Ruijin Hospital Affiliated to Shanghai Jiaotong University, China</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Xiaoyuan Feng, MD, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Radiology Department, Huashan Hospital, Fudan University, China</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Yanqing Hua, MD, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Radiology Department, Huadong Hospital Affiliated to Fudan University, China</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Mengsu Zeng, MD, PhD</last_name>
    <phone>+86-021-64041990-2130</phone>
    <email>zengmengsu@gmail.com</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Xiuzhong Yao, MD, PhD</last_name>
    <phone>+86-021-64041990-5425</phone>
    <email>fjqzyaoxz02@163.com</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Radiology Department, Ruijing Hospital, Shanghai Jiaotong University</name>
      <address>
        <city>Shanghai</city>
        <state>Shanghai</state>
        <zip>200025</zip>
        <country>China</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Fuhua Yan, MD, PhD</last_name>
      <phone>+86-13764236797</phone>
      <email>Lin-xiaozhu-rj@hotmail.com</email>
    </contact>
    <investigator>
      <last_name>Fuhua Yan, MD, PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Radiology Department, Cancer Hospital, Fuandan University</name>
      <address>
        <city>Shanghai</city>
        <state>Shanghai</state>
        <zip>200032</zip>
        <country>China</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Weijun Peng, Md, PhD</last_name>
      <phone>+86-13564682870</phone>
      <email>Huizhu171717@163.com</email>
    </contact>
    <investigator>
      <last_name>Weijun Peng, MD, PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Radiology Department, Zhongshan Hospital, Fudan University</name>
      <address>
        <city>Shanghai</city>
        <state>Shanghai</state>
        <zip>200032</zip>
        <country>China</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Mengsu Zeng, MD, PhD</last_name>
      <phone>+86-021-64041990-2130</phone>
      <email>zengmengsu@gmail.com</email>
    </contact>
    <investigator>
      <last_name>Mengsu Zeng, MD, PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Radiology Department, Huadong Hospital, Fudan University</name>
      <address>
        <city>Shanghai</city>
        <state>Shanghai</state>
        <zip>200040</zip>
        <country>China</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Yanqing Hua, MD, PhD</last_name>
      <phone>+86-13774234090</phone>
      <email>13774234090@163.com</email>
    </contact>
    <investigator>
      <last_name>Yanqing Hua, MD, PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Radiology Department, Huashan Hospital, Fudan University</name>
      <address>
        <city>Shanghai</city>
        <state>Shanghai</state>
        <zip>200040</zip>
        <country>China</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Xiaoyuan Feng, MD, PhD</last_name>
      <phone>+86-13601659304</phone>
      <email>liangzh@vip.163.com</email>
    </contact>
    <investigator>
      <last_name>Xiaoyuan Feng, MD, PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Radiology Department, Changhai Hospital Affiliated to the Second Military Medical University</name>
      <address>
        <city>Shanghai</city>
        <state>Shanghai</state>
        <zip>200433</zip>
        <country>China</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Jianping Lu, MD, PhD</last_name>
      <phone>+86-13701775219</phone>
      <email>13701775219@163.com</email>
    </contact>
    <investigator>
      <last_name>Jianping Lu, MD, Phd</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>China</country>
  </location_countries>
  <verification_date>October 2011</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>October 18, 2011</study_first_submitted>
  <study_first_submitted_qc>October 19, 2011</study_first_submitted_qc>
  <study_first_posted type="Estimate">October 20, 2011</study_first_posted>
  <last_update_submitted>October 19, 2011</last_update_submitted>
  <last_update_submitted_qc>October 19, 2011</last_update_submitted_qc>
  <last_update_posted type="Estimate">October 20, 2011</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor-Investigator</responsible_party_type>
    <investigator_affiliation>Shanghai Zhongshan Hospital</investigator_affiliation>
    <investigator_full_name>Meng Su Zeng</investigator_full_name>
    <investigator_title>Mengsu Zeng, MD &amp; Ph.D,Chairman &amp; Professor,Department of Radiology</investigator_title>
  </responsible_party>
  <keyword>Computed tomography</keyword>
  <keyword>Contrast enhancement</keyword>
  <keyword>Pancreas</keyword>
  <keyword>Cancer</keyword>
  <keyword>Resectability</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Adenocarcinoma</mesh_term>
    <mesh_term>Head and Neck Neoplasms</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

